Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) developed by the Institute of Molecular Genetics of the Russian Academy of Sciences as a stable analogue of the endogenous immunomodulatory peptide tuftsin. It has attracted significant research interest due to its anxiolytic, nootropic, and neuroprotective properties, which appear to operate without the sedative or dependency-forming effects associated with classical anxiolytic compounds.
Mechanistically, Selank is understood to modulate GABAergic neurotransmission and influence the expression of brain-derived neurotrophic factor (BDNF), as well as enkephalin degradation, potentially prolonging endogenous opioid activity. Research suggests it may also regulate serotonin metabolism and stabilise levels of interleukin-6, positioning it as a compound of interest in studies examining stress, anxiety, immune modulation, and cognitive enhancement.
In preclinical and early clinical research contexts, Selank has been investigated for its potential to improve memory consolidation, attentional performance, and adaptive stress responses. It is also studied in relation to neuroinflammation and immune dysregulation.
Specifications: Molecular Formula: C₃₃H₅₇N₁₁O₉ | Molecular Weight: 751.88 g/mol | Purity: >98% | CAS Number: 129954-34-3 | Form: Lyophilised Powder.
Storage: Store at -20°C. Protect from light and moisture. Stable for 24 months when stored correctly.
Molecular Formula
C₃₃H₅₇N₁₁O₉
Molecular Weight
751.88 g/mol
Purity
>98%
CAS Number
129954-34-3
Form
Lyophilised Powder
Research Applications
Anxiolytic research, Nootropic and cognitive function studies, Stress and adaptive response modulation, Neuroinflammation, Immunomodulation, BDNF expression research
For research purposes only. Not for human use.


Reviews
There are no reviews yet.